Gen Z's ‘Main Character Energy' Is Running Low, According to New Survey on Mental Well-Being
BOULDER, Colo., June 24, 2025--(BUSINESS WIRE)--As college students might say: the "vibes are off" across the country. A staggering 94% of Americans say they sometimes feel mentally overwhelmed, and the crisis cuts deep for Gen Z (ages 18-28) at 97%. A new survey conducted online by The Harris Poll for Naropa University, a leader in mindfulness education and one of Colorado's top educators of mental health counselors, paints a sobering picture. Many Gen Z (i.e., Zoomers) see themselves as helpers, are emotionally overloaded and unsure how to find relief.
More than two-thirds (68%) of Zoomers agree that they often put other people's emotional needs ahead of their own, and 61% report that they don't know where to turn when they feel emotionally overwhelmed. While more than 80% of Gen Z are on social media, it may not be able to deliver the support they need.
"We commissioned this survey to better understand how people, especially younger generations, emotionally navigate in today's world," said Charles G. Lief, President of Naropa University. "The mental health issues experienced today require fresh approaches to how mental health professionals are trained. That includes recognizing and anticipating the very real risk of professional burnout experienced by therapists, teachers, first responders and others in the helping professions."
A Social Media Paradox: Mental Health Trends Aren't Enough
Starkly compared to a minority of Gen X ages 45-60 (43%) and Baby Boomers ages 61-79 (18%), a majority of Gen Z and Millennials ages 29-44 (63% each) agree they often find mental health information on social media (e.g., TikTok, YouTube, Instagram). Both generations feel like the information is falling short, with 58% of Gen Z and 61% of Millennials agreeing that finding self-care tips online is as helpful as putting a band-aid on a broken bone.
"Gen Zers are emotionally intelligent and aware, but they are stressed," said Azara Santiago-Rivera, Ph.D., Dean of Graduate Psychology at Naropa University. "Gen Zers are open to receiving mental health services and are proactive in seeking such services, including online services. That openness has led to increased demand for services. Our findings show a generation hungry for deeper, more meaningful self-care than the superficial tips they find online."
What Gen Z Coping Looks Like
Gen Zers report some of the ways they are coping with being mentally overwhelmed include:
29% doomscroll—more than any other generation (17% Millennials, 6% Gen X and 2% Boomers);
47% binge-watch TV;
27% use retail therapy; and
64% listen to music
Yet, 31% report touching grass (i.e. engaging with the real world) as a coping tactic, more than any other generation (24% Millennials, 16% Gen X and 15% Boomers). Nearly a third (31%) of Gen Z report going off the grid (i.e.., taking a break from technology/social media) to deal. "These are insightful techniques," remarked Santiago-Rivera, "that can open people up to a more formal introduction of mindfulness and other contemplative tools to break out of the mental overload which is negatively affecting anyone seeking a level of relief and healing."
Zoomers Are Running on Empty, Some Feel Like NPCs
Gen Z are less likely than Millennials to report full energy levels when thinking about the state of the world. Imagining themselves as characters in a video game, only 19% describe their energy levels as full, compared to 26% of Millennials. Nearly one in 10 (8%) of Gen Z say they feel like an NPC (non-playable character) when thinking about the state of the world, perhaps indicating growing disassociation and nihilism.
Survey Method
This survey was conducted online within the United States by The Harris Poll on behalf of Naropa University from May 6-8, 2025, among 2,085 adults ages 18+, among whom 391 are Gen Z (ages 18-28). The sampling precision of Harris online polls is measured by using a Bayesian credible interval. For this study, the sample data is accurate to within +/- 2.5 percentage points using a 95% confidence level.
Email the contact information below for more information on the survey or additional generational data. Gen Z data can be found here. To learn about Naropa's contemplative education programs and approach to mindfulness, visit naropa.edu/academics.
About Naropa University
Naropa University, nestled in Boulder, Colorado, was established in 1974 by Tibetan Buddhist teacher Chögyam Trungpa Rinpoche. Drawing its name and inspiration from the teachings of the 11th-century Indian Buddhist sage Naropa, this private university stands out distinctly among America's higher education landscape in its effort to integrate eastern wisdom with traditional western scholarship. Recognized as the pioneering force behind contemplative higher education and the start of the modern mindfulness movement, Naropa University is the sole institution to integrate a university-wide contemplative pedagogical approach. At Naropa, education transcends the ordinary; the institution embraces the entirety of its students—mind, body and spirit—augmenting traditional methodologies with practices like meditation. Since receiving its accreditation in 1986, Naropa University consistently upholds the exacting standards for quality and accountability set by the Higher Learning Commission (HLC). Learn more at naropa.edu.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250624434731/en/
Contacts
Media Contact Molly SposatoGrasslands: A Journalism-Minded AgencyMolly@MyGrasslands.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
an hour ago
- Business Wire
CORRECTING and REPLACING Polio Vaccination Campaign Planned in Afghanistan with PharmaJet
GOLDEN, Colo.--(BUSINESS WIRE)--Please replace the release dated Aug. 19, 2025 with the following corrected version due to multiple revisions - removing mentions of WHO and UNICEF and all operational details which are subject to national authorities and partners agreement. The updated release reads: Polio Vaccination Campaign Planned in Afghanistan with PharmaJet ® Tropis ® ID Delivery System PharmaJet has been awarded a tender to support the first large-scale implementation of intradermal (ID) polio immunization in Afghanistan. PharmaJet's award builds on the successful implementation of Tropis for ID delivery in polio vaccination campaigns in Pakistan, Nigeria, and Somalia. The use of Tropis ID in polio vaccination campaigns has improved vaccine coverage, decreased immunization program costs, and increased acceptability. PharmaJet ®, a company that strives to improve the performance and outcomes of injectables with its enabling needle-free injection technology, today announced that the WHO prequalified Tropis ID delivery system will be used to support a polio eradication campaign in Afghanistan. Poliovirus has been eliminated in most parts of the world due to widespread vaccination campaigns, but it continues to circulate in Afghanistan and Pakistan. In 2024, wild poliovirus type 1 (WPV1) transmission rose significantly in Afghanistan. The use of Tropis ID enables site-to-site immunization, a strategy where vaccination services are offered at multiple, convenient locations. Including Tropis ID fractional doses of inactivated polio vaccine (fIPV) in this immunization program supports Afghanistan's polio eradication goals to eliminate persistent virus lineages, prevent new WPV1 cases, and prevent local transmission. 'We are pleased to be supporting Afghanistan in their continued efforts to eradicate polio,' said Paul LaBarre, Senior Vice President Global Business Development, PharmaJet. 'We aim to achieve high impact in the fight against poliovirus, including increased coverage, decreased costs, and high acceptability 1 previously seen with Tropis ID delivered fIPV in Pakistan, 1 Somalia, 2 and Nigeria 3.' Refer to Instructions for Use to ensure safe injections and to review risks. About PharmaJet The PharmaJet mission is to improve the performance and outcomes of injectables with our enabling technology that better activates the immune system. We are committed to helping our partners realize their research and commercialization goals while making an impact on public health. PharmaJet Precision Delivery Systems™ can improve vaccine effectiveness, allow for a preferred patient and caregiver experience, and offer a proven path to commercialization. They are also safe, fast, and easy-to-use. The Stratis ® System has U.S. FDA 510(k) marketing clearance, CE Mark, and WHO PQS certification to deliver medications and vaccines either intramuscularly or subcutaneously. The Tropis ® System has CE Mark and WHO PQS certification for intradermal injections. They are both commercially available for global immunization programs. For more information or if you are interested in partnering with PharmaJet visit or contact PharmaJet here. Follow us on LinkedIn.
Business Wire
2 hours ago
- Business Wire
New Survey: College Students Feel Coerced Into Participating in Animal Experiments Despite Objections; 83% Oppose Such Exercises
WASHINGTON--(BUSINESS WIRE)--Eighty-three percent of U.S. college students believe that animals should not be used in classroom teaching laboratories if the animals are killed afterward and if other methods can teach the same material without using animals, according to a new OpinionWorks survey. Among those majoring in the sciences, 90% believe animals should not be used. The survey, which was conducted online among 1,043 U.S. undergraduate college students from Aug. 8 to 10, 2025, also posed the hypothetical scenario in which such an animal laboratory was offered as an optional experience, along with a nonanimal alternative. In that case, although most students did not want to participate, 20% stated they would do so anyway to avoid problems, and another 24% stated that they would be nervous asking for the alternative activity. The survey also found an overwhelming majority of students, 79%, expressed concern about the welfare of animals. 'The vast majority of college students don't want to participate in deadly animal experiments in the classroom but feel subtly coerced because they are fearful of the consequences of not taking part,' says Neal Barnard, MD, president of the Physicians Committee for Responsible Medicine. 'Colleges with old-fashioned animal labs put students in an awful position that many interpret as a choice between killing or flunking.' The survey results arrive amid an ongoing lawsuit against fatal animal experiments at Macalester College in Saint Paul, Minn., where students will begin arriving for the new school year on Aug. 25. In psychology courses at Macalester, live animals are deprived of water for prolonged periods, then placed in 'Skinner boxes,' where they have to work for water. Some experiments involve drugging animals and placing them in mazes. All are killed at the conclusion of the experiments. Harvard, Yale, Stanford, Princeton, and other leading universities stopped the Macalester-style fatal experiments long ago. The new survey found that 76% of college students do not approve of the use of live animals in psychology classes when the animals are killed afterward and when there are alternative teaching methods. Macalester's website says that its 'animal welfare standards and ethical principles are applied at the highest possible level in any animal use or research conducted at or in association with the college' and that it follows the federal Animal Welfare Act, which incorporates ethical principles called the Three Rs—for the replacement, reduction, and refinement of animal use in research. A lawsuit against Macalester, brought by alumnus Dr. Barnard on June 3, calls on the college to stop needlessly killing animals in psychology classes' 'show and tell' exercises, citing the college's posted ethics commitment. The psychology department has killed thousands of animals for more than 50 years. The college stated in its motion to dismiss, which Dr. Barnard responded to in court papers, that its own ethics statements are mere 'generic phrases'—known legally as 'puffery.' The college wrote, 'These statements are, at most, 'vague or highly subjective' statements of superiority—not representations of material fact,' drawing comparisons with statements used to sell dog food or breakfast cereal. 'Given that animals' lives are at stake, Macalester's brazen statement that it did not really mean its ethics policy is an affront to students, donors, the faculty, and the public,' Dr. Barnard said. The lawsuit seeks, among other actions, an order compelling Macalester 'to cease its use of animal laboratories in psychology instruction and in all other areas for which nonanimal methods are available.' To speak with Dr. Barnard, please contact Michael Keevican at 202-527-7367 or mkeevican@ Founded in 1985, the Physicians Committee for Responsible Medicine is a nonprofit organization that promotes preventive medicine, conducts clinical research, and encourages higher standards for ethics and effectiveness in education and research.
Business Wire
3 hours ago
- Business Wire
Develop Health Raises $14.3M to Automate Prior Authorization and Medication Access Using GenAI
SAN FRANCISCO--(BUSINESS WIRE)-- Develop Health, an EHR-integrated benefits‑verification and prior‑authorization platform, today announced a $14.3 million Series A led by Wing Venture Capital, with participation from Afore Capital, J Ventures, and South Park Commons. The round brings the company's total funding to $17.6 million. Built with over a dozen purpose-built large language model pipelines, Develop Health is the first medication access platform fully architected around GenAI. Its EHR-integrated platform plugs into virtual care workflows to verify insurance coverage in real time, generate and submit the correct prior authorization package, follow up and track status continuously, and return structured data back into the provider's system, all without manual effort from care teams. Founded by Mel van Londen and Benjamin Easton, Develop Health is tackling a growing bottleneck in healthcare: the administrative complexity that delays access to necessary medications. Before Develop Health, the founders held roles at provider-facing healthcare startups Canvas Medical and Rupa Health, where they saw how poor communication and data fidelity between providers and payers led to delayed treatment, lost revenue, and worse outcomes for patients. 'We believe providers should be able to make care decisions with full visibility into a patient's plan, because a prescription that isn't affordable or accessible is no prescription at all,' said Mel van Londen, co-founder and CEO of Develop Health. 'We're building healthcare's agentic clearinghouse, starting with medication access and designing infrastructure that meets both payers and providers where they are.' The new funding will fuel Develop Health's expansion beyond its core work helping digital health companies navigate the pharmacy benefit space—spanning GLP-1s and treatments across addiction, neurology, dermatology, and psychiatry—into the medical benefit market. The company will also deepen its integrations with both EHRs and PBMs, streamlining and scaling the link between prescribing and coverage, and extend its reach into traditional providers outside of digital health. 'Develop Health is solving one of the most frustrating pain points in healthcare – getting patients the medications they need without weeks of paperwork and endless back-and-forth,' said Sara Choi, Partner at Wing Venture Capital. 'They've built a system that puts GenAI to work in one of the industry's most critical, overlooked workflows. Develop Health is positioned to become essential infrastructure for any provider dealing with medication access complexity. ' Today, Develop Health helps providers reduce churn, set clearer patient expectations, and streamline access to care. The platform reduces form completion time by over 80% and increases approval rates, improving both provider efficiency and patient experience. In just three months, the company has grown significantly and is on track to helping over 1 million patients access their medications by the end of this year. That traction has been driven by Develop Health's exceptional team of engineers, including Jack Collins, Juan de Urtubey, and Zygimantas Koncius, whose technical excellence has made the platform possible. About Develop Health Develop Health's mission is to empower providers by eliminating the friction of prior authorization and improving visibility into plan benefits—freeing up capacity to deliver truly high-quality patient care. At its core, Develop Health is healthcare's agentic clearinghouse, beginning with medication access. Today, the platform supports hundreds of thousands of patients each month in getting the treatments they need—while reducing administrative work related to medication access by 83%. Learn more at
